Myogenic tumors in children and adolescents

Pediatric and Developmental Pathology

Volumn 15, Issue SUPPL. 1, 2012, Pages 211-238

  Parham, David M ^a   Alaggio, Rita ^b   Coffin, Cheryl M ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Leiomyoma; Leiomyosarcoma; Muscle tumors; Rhabdomyoma; Rhabdomyosarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE;

ANAPLASTIC RHABDOMYOSARCOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; DIFFERENTIAL DIAGNOSIS; ECTOMESENCHYMOMA; ELECTRON MICROSCOPY; EMBRYONAL RHABDOMYOSARCOMA; FETAL RHABDOMYOMA; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GROUPS BY AGE; HEART RHABDOMYOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOMATOSIS; LEIOMYOSARCOMA; MUSCLE TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHABDOMYOMATOUS HAMARTOMA; RHABDOMYOSARCOMA; SCLEROSING RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE HAMARTOMA;

ADOLESCENT; CHILD; HUMANS; MUTATION; NEOPLASMS, MUSCLE TISSUE; TREATMENT OUTCOME;

EID: 84858763270     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-12-0953-PB.1     Document Type: Review

References (278)

1. Heij HA, Vos A, De Kraker J, Voute PA. Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified. J Urol 1993;150:165-168. (Pubitemid 23175996)
2. Spunt SL, Lobe TE, Pappo AS, et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 2000;35:309-316. (Pubitemid 30082590)
3. Buckingham M, Bajard L, Chang T, et al. The formation of skeletal muscle: from somite to limb. J Anatomy 2003;202:59-68. (Pubitemid 36503969)
4. Arnold HH, Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Devel 1998; 8:539-544. (Pubitemid 28477356)
5. Dias P, Dilling M, Houghton P. The molecular basis of skeletal muscle differentiation. Sem Diag Pathol 1994;11:3-14. (Pubitemid 24092131)
6. Tiffin N, Williams RD, Shipley J, Pritchard-Jones K. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br J Cancer 2003;89:327-332. (Pubitemid 36976324)
7. Hasty P, Bradley A, Morris JH, et al. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993;364:501-506. (Pubitemid 23273093)
8. Olson EN, Arnold HH, Rigby PWJ, Wold BJ. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 1996;85:1-4. (Pubitemid 26116800)
9. Erlandson RA. The ultrastructural distinction between rhabdomyosarcoma and other undifferentiated "sarcomas." Ultrastruct Pathol 1987;11:83-101. (Pubitemid 17076957)
10. Molkentin JD, Black BL, Martin JF, Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 1995;83;125-136.
11. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, Peterson CA. Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 1993;118:1137-1147. (Pubitemid 23252403)
12. Gulati AK. Long-term retention of regenerative capability after denervation of skeletal muscle, and dependency of late differentiation on innervation. Anat Rec 1988;220:429-434.
13. Merlino G, Helman LJ, Merlino G, Helman LJ. Rhabdomyosarcoma: working out the pathways. Oncogene 1999;18:5340-5348.
14. Ruymann FB. Rhabdomyosarcoma in children and adolescents: a review. Hematol Oncol Clin North Am 1987;1:621-654.
15. Enzinger FM, Weiss SW. Soft Tissue Tumors, 2nd ed. St Louis: The C.V. Mosby Company, 1988.
16. Newton WA Jr, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcoma and related sarcomas: pathologic aspects and proposal for a new classification. An Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073-1085.
17. Newton WA Jr, Soule EH, Hamoudi AB, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol 1988;6:67-75. (Pubitemid 18039993)
18. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
19. Davicioni E, Anderson MJ, Finckenstein FG, et al. Molecular classification of rhabdomyosarcoma: genotypic and phenotypic determinants of diagnosis. A report from the Children's Oncology Group. Am J Pathol 2009;174:550-564.
20. Chiles MC, Parham DM, Qualman SJ, et al. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. [Erratum appears in Pediatr Dev Pathol 2005;8:141]. Pediatr Devel Pathol 2004;7:583-594.
21. Qualman S, Lynch J, Bridge J, et al. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer 2008;113:3242-3247.
22. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 2006;130:1454-1465. (Pubitemid 44520712)
23. Sotelo-Avila C, Gooch WM. Neoplasms associated with the Beckwith-Wiedemann syndrome. Perspct Pediatr Pathol 1976;3:255-272.
24. Hahn H, Wojnowski L, Zimmer AM, et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome [see comments]. Nat Med 1998;4:619-622. (Pubitemid 28237364)
25. Gripp KW, Scott CI Jr, Nicholson L, et al. Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. Am J Med Genet 2002;108:80-87.
26. Matsui I, Tanimura M, Kobayashi N, et al. Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746-2754. (Pubitemid 23320242)
27. Khayat CM, Johnston DL. Rhabdomyosarcoma, osteosarcoma, and adrenocortical carcinoma in a child with a germline p53 mutation. Pediatr Blood Cancer 2004;43:683-686. (Pubitemid 39411233)
28. Limwongse C, Schwartz S, Bocian M, et al. Child with mosaic variegated aneuploidy and embryonal rhabdomyosarcoma. Am J Med Genet 1999;82:20-24. (Pubitemid 29022293)
29. Meyer S, Kingston H, Taylor AM, et al. Rhabdomyosarcoma in Nijmegen breakage syndrome: strong association with perianal primary site. Cancer Genet Cytogenet 2004;154:169-174. (Pubitemid 39345814)
30. Sobel RA, Woerner S. Rubinstein-Taybi syndrome and nasopharyngeal rhabdomyosarcoma. J Pediatr 1981;99:1000-1001.
31. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009;325:965.
32. Kratz CP, Holter S, Etzler J, et al. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome. J Med Genet 2009;46:418-420.
33. Armstrong SJ, Duncan AW, Mott MG. Rhabdomyosarcoma associated with familial adenomatous polyposis. Pediatr Radiol 1991;21:445-446.
34. Slater O, Shipley J. Clinical relevance of molecular genetics to paediatric sarcomas. J Clin Pathol 2007;60:1187-1194. (Pubitemid 350084537)
35. Bisogno G, Murgia A, Mammi I, et al. Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome. J Pediatr Hematol Oncol 1999;21:424-427. (Pubitemid 30306014)
36. Zahm SH, Fraumeni JF Jr. The epidemiology of soft tissue sarcoma. Semin Oncol 1997;24:504-514. (Pubitemid 27449586)
37. Tassabehji M, Read AP, Newton VE, et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene [see comments]. Nature 1992;355:635-636.
38. Merks JH, Caron HN, Hennekam RC. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A 2005;134A:132-143. (Pubitemid 40446208)
39. Yang P, Grufferman S, Khoury MJ, et al. Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects. Genetic Epidemiol 1995;12:467-474.
40. Bisogno G, Sotti G, Nowicki Y, et al. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group. Cancer 2004;100:1758-1765. (Pubitemid 38456356)
41. Kodet R, Fajstavr J, Kabelka Z, et al. Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies I, II, and III. Cancer 1991;67:2907-2913.
42. Coffin CM, Rulon J, Smith L, Bruggers C, White FV. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 1997;10:1175-1187.
43. Lollini P-L, De Giovanni C, Del Re B, et al. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res 1989;49:3631-3536.
44. Qualman SJ, Coffin CM, Newton WA, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Devel Pathol 1998;1:550-561. (Pubitemid 128542175)
45. Smith LM, Anderson JR, Qualman SJ, et al. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2001;19:4058-4064. (Pubitemid 32976693)
46. Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyosarcoma: a prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 1992;16:229-235.
47. Leuschner I, Newton WA Jr, Schmidt D, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: a report of the intergroup rhabdomyosarcoma study. Am J Surg Pathol 1993;17:221-230. (Pubitemid 23085916)
48. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms' tumor-new definitions with prognostic significance: a report from the National Wilms' Tumor Study Group. Am J Surg Pathol 1996;20:909-920. (Pubitemid 26250632)
49. Chen B, Dias P, Jenkins JJ, Savell VH, Parham DM. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 1998;152:1071-1079. (Pubitemid 28173369)
50. Bridge JA, Liu J, Weibolt V, et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an Intergroup Rhabdomyosarcoma Study. Genes Chromosom Cancer 2000;27:337-344. (Pubitemid 30127620)
51. Pandita A, Zielenska M, Thorner P, et al. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia (New York) 1999;1:262-275.
52. Weber-Hall S, Anderson J, McManus A, et al. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996;56:3220-3224. (Pubitemid 26242966)
53. Bridge JA, Liu J, Qualman SJ, et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 2002;33:310-321. (Pubitemid 34130938)
54. Xia SJ, Pressey JG, Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 2002;1:97-104.
55. Scrable H, Witte D, Shimada H, et al. Molecular differential pathology in rhabdomyosarcoma. Genes Chromosom Cancer 1989;1:23-35.
56. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 1989;86:7480-7484. (Pubitemid 19254480)
57. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985;316:330-334. (Pubitemid 15237805)
58. Steenman M, Westerveld A, Mannens M. Genetics of Beckwith- Wiedemann syndrome-associated tumors: common genetic pathways. Genes Chromosom Cancer 2000;28:1-13. (Pubitemid 30176757)
59. Cooper WN, Luharia A, Evans GA, et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2005;13:1025-1032. (Pubitemid 43073609)
60. Cohen MM Jr. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005;8:287-304.
61. Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005;137C:12-23. (Pubitemid 41113659)
62. Anderson J, Gordon A, McManus A, Shipley J, Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1999;1:340-348.
63. Cam H, Griesmann H, Beitzinger M, et al. p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 2006;10:281-293. (Pubitemid 44512191)
64. Riopelle JL, Thériault JP. Sur une forme méconnue de sarcome des parties molles: le rhabdomyosarcome alvéolaire. Ann Anat Pathol (Paris) 1956;1:88-111.
65. Tsokos M, Webber B, Parham D, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med 1992;116:847-855.
66. Dias P, Chen B, Dilday B, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol 2000;156:399-408. (Pubitemid 30643794)
67. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001;25:1150-1157. (Pubitemid 32777714)
68. Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol 2002;9:198-203.
69. Bahrami A, Gown AM, Baird GS, Hicks MJ, Folpe AL. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol 2008;21:795-806. (Pubitemid 351896668)
70. Heerema-McKenney A, Wijnaendts LCD, Pulliam JF, et al. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Am J Surg Pathol 2008;32:1513-1522.
71. Douglass EC, Rowe ST, Valentine M, et al. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosom Cancer 1991;3:480-482.
72. Williamson D, Missiaglia E, de Reynies A, et al. Fusion genenegative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010;28:2151-2158.
73. Wexler LH, Ladanyi M. Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation. J Clin Oncol 2010;28:2126-2128.
74. Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 2002;20:2672-2679. (Pubitemid 34575640)
75. Barr FG, Qualman SJ, Macris MH, et al. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 2002;62:4704-4710.
76. Wachtel M, Dettling M, Koscielniak E, et al. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 2004;64:5539-5545. (Pubitemid 39095545)
77. Sumegi J, Streblow R, Frayer RW, et al. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAXFOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010;49:224-236.
78. Kodet R, Newton WA Jr, Hamoudi AB, Asmar L, Jacobs DL, Maurer HM. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features: a report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1993;17:443-453. (Pubitemid 23121774)
79. Gordon A, McManus A, Anderson J, et al. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case. Cancer Genet Cytogenet 2003;140:73-77. (Pubitemid 36110645)
80. Mentzel T, Katenkamp D. Sclerosing, pseudovascular rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 2000;436:305-311. (Pubitemid 30219226)
81. Bale PM, Reye RDK. Rhabdomyosarcoma in childhood. Pathology 1975;7:101-111.
82. Croes R, Debiec-Rychter M, Cokelaere K, De VR, Hagemeijer A, Sciot R. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma. Virchows Archiv 2005;446:64-67. (Pubitemid 40179159)
83. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 2002;26:1175-1183.
84. Bouron-Dal SD, Rougemont AL, Absi R, et al. SNP genotyping of a sclerosing rhabdomyosarcoma: reveals highly aneuploid profile and a specific MDM2/HMGA2 amplification. Hum Pathol 2009;40: 1347-1352.
85. Zuppan CW, Mierau GW, Weeks DA. Lipid-rich rhabdomyosarcoma: a potential source of diagnostic confusion. Ultrastruct Pathol 1991;15:353-359.
86. Boman F, Champigneulle J, Schmitt C, Beurey P, Floquet J, Boccon-Gibod L. Clear cell rhabdomyosarcoma. Pediatr Pathol Lab Med 1996;16:951-959. (Pubitemid 26394014)
87. Miki H, Kobayashi S, Kushida Y, et al. A case of infantile rhabdomyofibrosarcoma with immunohistochemical, electronmicroscopical, and genetic analyses. Hum Pathol 1999;30:1519-1522. (Pubitemid 30032931)
88. Lundgren L, Angervall L, Stenman G, Kindblom LG. Infantile rhabdomyofibrosarcoma: a high-grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma. Hum Pathol 1993;24:785-795. (Pubitemid 23204658)
89. Palazzo JP, Gibas Z, Dunton CJ, Talerman A. Cytogenetic study of botryoid rhabdomyosarcoma of the uterine cervix. Virchows Arch A Pathol Anat Histopathol 1993;422:87-91. (Pubitemid 23073670)
90. Boue DR, Parham DM, Webber B, Crist WM, Qualman SJ. Clinicopathologic study of ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV. Pediatr Dev Pathol 2000;3:290-300. (Pubitemid 30232857)
91. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T. Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosom Cancer 1992;5:299-310. (Pubitemid 23011199)
92. Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res 1995;55:1385-1392.
93. Floris G, Debiec-Rychter M, Wozniak A, et al. Malignant ectomesenchymoma: genetic profile reflects rhabdomyosarcomatous differentiation. Diagn Mol Pathol 2007;16:243-248. (Pubitemid 350196983)
94. Sebire NJ, Ramsay AD, Malone M, Risdon RA. Extensive posttreatment ganglioneuromatous differentiation of rhabdomyosarcoma: malignant ectomesenchymoma in an infant. Pediatr Dev Pathol 2003;6:94-96. (Pubitemid 36323633)
95. Gaffney EF, Dervan PA, Fletcher CDM. Pleomorphic rhabdomyosarcoma in adulthood: analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol 1993;17:601-609. (Pubitemid 23152598)
96. Wesche WA, Fletcher CDM, Dias P, Houghton PJ, Parham DM. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995;19:261-269.
97. Tallini G, Parham DM, Dias P, Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas: a sensitive and specific marker of skeletal muscle differentiation. Am J Pathol 1994;144:693-701. (Pubitemid 24172058)
98. Nascimento AF, Fletcher CD. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol 2005;29:1106-1113. (Pubitemid 41045557)
99. Mierau GW, Berry PJ, Orsini EN. Small round cell neoplasms: can electron microscopy and immunohistochemical studies accurately classify them. Ultrastruct Pathol 1985;9:99-111. (Pubitemid 16189769)
100. Graf FF, Shahbazian V, Davicioni E, et al. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 2008;27:2004-2014. (Pubitemid 351442734)
101. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-1810.
102. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal musclespecific markers. Mod Pathol 2001;14:595-603. (Pubitemid 32554085)
103. Morotti RA, Nicol KK, Parham DM, et al. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am J Surg Pathol 2006;30:962-968. (Pubitemid 44264944)
104. Wachtel M, Runge T, Leuschner I, et al. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol 2006; 24: 816-822. (Pubitemid 46622049)
105. Nishio J, Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 2006;86:547-556. (Pubitemid 43780436)
106. Barr FG, Smith LM, Lynch JC, et al. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group. J Mol Diagn 2006;8:202-208. (Pubitemid 43811243)
107. Barr FG, Nauta LE, Davis RJ, Schäfer BW, Nycum LM, Biegel JA. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 1996;5:15-21. (Pubitemid 26018269)
108. Barr FG, Duan F, Smith LM, et al. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Genes Chromosom Cancer 2009;48:661-672.
109. Parham DM. Modern diagnosis of small cell malignancies in children. In: Parham DM, ed. Surgical Pathology Clinics: Current Concepts in Pediatric Pathology. Volume 3. Amsterdam: Elsevier, 2010;515-551.
110. Ellison DA, Adada B, Qualman SJ, et al. Melanotic neuroectodermal tumor of infancy: report of a case with myogenic differentiation. Pediatr Devel Pathol 2007;10:157-160. (Pubitemid 46580411)
111. Ordonez NG. Desmoplastic small round cell tumor. II. An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998;22:1314-1327. (Pubitemid 28499122)
112. Folpe AL, Weiss SW, Fletcher CD, Gown AM. Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. Mod Pathol 1998;11:939-944. (Pubitemid 28487211)
113. Parham DM, Dias P, Kelly DR, Rutledge JC, Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992;16:483-492.
114. Fletcher CDM. Angiomatoid "malignant" fibrous histiocytoma: an immunohistochemical study indicative of myoid differentiation. Hum Pathol 1991;22:563-568.
115. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002;15:931-938.
116. Coindre J-M, De Mascarel A, Trojani M, De Mascarel I, Pages A. Immunohistochemical study of rhabdomyosarcoma: unexpected staining with S100 protein and cytokeratin. J Pathol 1988;155:127-232.
117. Kodet R, Newton WA Jr, Sachs N, et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum Pathol 1991;22:674-684.
118. Kodet R, Newton WA Jr, Hamoudi AB, Asmar L. Rhabdomyosarcomas with intermediate-filament inclusions and features of rhabdoid tumors: light microscopic and immunohistochemical study. Am J Surg Pathol 1991;15:257-267.
119. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004;28:1485-1491. (Pubitemid 39425515)
120. Wigger HJ. Fetal rhabdomyomatous nephroblastoma: a variant of Wilms' tumor. Hum Pathol 1976;7:613-623. (Pubitemid 8005760)
121. Dehner LP. Pleuropulmonary blastoma is THE pulmonary blastoma of childhood. Semin Diagn Pathol 1994;11:144-151. (Pubitemid 24273783)
122. Woodruff JM, Chernik NL, Smith MC, Millett WB, Foote FW Jr. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors). Cancer 1973;32:426-439.
123. Reith JD, Bauer TW, Fischler DF, Joyce MJ, Marks KE. Dedifferentiated chondrosarcoma with rhabdomyosarcomatous differentiation. Am J Surg Pathol 1996;20:293-298. (Pubitemid 26071510)
124. Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol 1994;11:69-81. (Pubitemid 24092137)
125. Prat J, Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer 1982;50:2465-2475. (Pubitemid 13244185)
126. Carstens PHB, Cooke JL. Mammary carcinosarcoma presenting as rhabdomyosarcoma: an ultrastructural and immunocytochemical study. Ultrastruct Pathol 1990;14:537-544.
127. Schmitt FC, Bittencourt A, Mendonca N, Dorea M. Rhabdomyosarcoma in a congenital pigmented nevus. Pediatr Pathol 1992;12:93-98.
128. Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. Am J Pediatr Hematol Oncol 2001;23:215-220. (Pubitemid 32524925)
129. Wharam MD, Meza J, Anderson J, et al. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 2004;22:1902-1908. (Pubitemid 41095182)
130. Pappo AS, Lyden E, Breitfeld P, et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. J Clin Oncol 2007;25:362-369. (Pubitemid 350002984)
131. Anderson JR, Barr FG, Hawkins DS, et al. Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature. J Clin Oncol 2010;28:e587-e588.
132. Smith LM, Anderson JR, Coffin CM. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). Med Pediatr Oncol 2002;38:398-404. (Pubitemid 34507283)
133. Arndt CA, Hammond S, Rodeberg D, Qualman S. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: results from IRS IV. J Pediatr Hematol Oncol 2006;28:563-567. (Pubitemid 44496332)
134. Khan J, Simon R, Bittner M, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998;58:5009-5013. (Pubitemid 28521149)
135. Carey KA, Segal D, Klein R, et al. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays. Pathol Int 2006;56:246-255.
136. Schofield D, Triche TJ. cDNA microarray analysis of global gene expression in sarcomas. Curr Opin Oncol 2002;14:406-411. (Pubitemid 34747976)
137. Cao L, Yu Y, Bilke S, et al. Genome-wide identification of PAX3- FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 2010;70:6497-6508.
138. Lager JJ, Lyden ER, Anderson JR, et al. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2006;24:3415-3422. (Pubitemid 46638898)
139. Arndt CA, Donaldson SS, Anderson JR, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 2001;91:2454-2468. (Pubitemid 32552835)
140. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment. Results of an International Workshop. J Clin Oncol 2001;19:197-204. (Pubitemid 32063497)
141. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, 4th ed. St Louis: Mosby, 2001.
142. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours: Pathology and Genetics of Soft Tissue and Bone. Lyon: IARC Press, 2002.
143. Wehner MS, Humphreys JL, Sharkey FE. Epididymal rhabdomyoma: report of a case, including histologic and immunohistochemical findings. Arch Pathol Lab Med 2000;124:1518-1519.
144. Tanda F, Rocca PC, Bosincu L, Massarelli G, Cossu A, Manca A. Rhabdomyoma of the tunica vaginalis of the testis: a histologic, immunohistochemical, and ultrastructural study. Mod Pathol 1997;10:608-611. (Pubitemid 27293502)
145. Burke A, Virmani R. Pediatric heart tumors. Cardiovasc Pathol 2008;17:193-198.
146. Tworetzky W, McElhinney DB, Margossian R, et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol 2003;92:487-489. (Pubitemid 36959896)
147. Meikle L, McMullen JR, Sherwood MC, et al. A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. Hum Mol Genet 2005;14:429-435. (Pubitemid 40220660)
148. Deeg KH, Voigt HJ, Hofbeck M, Singer H, Kraus J. Prenatal ultrasound diagnosis of multiple cardiac rhabdomyomas. Pediatr Radiol 1990;20:291-292. (Pubitemid 20120870)
149. Bjorkhem G, Lundstrom NR, Lingman G. Intracardiac rhabdomyomas in neonates: report of three cases. Acta Paediatr 1992;81:712-715.
150. Isaacs H Jr. Fetal and neonatal cardiac tumors. Pediatr Cardiol 2004;25:252-273.
151. Geva T, Santini F, Pear W, Driscoll SG, Van PR. Cardiac rhabdomyoma: rare cause of fetal death. Chest 1991;99:139-142.
152. Iliff PJ, Nicholls JM, Keeling JW, Gough JD. Non-immunologic hydrops fetalis: a review of 27 cases. Arch Dis Child 1983;58:979-982. (Pubitemid 14215837)
153. Abdel-Rahman U, Ozaslan F, Esmaeili A, Moritz A. A giant rhabdomyoma with left ventricular inflow occlusion and univentricular physiology. Thorac Cardiovasc Surg 2005;53:259-260. (Pubitemid 41153576)
154. Gazit AZ, Singh GK, Shumway J, Johnson MC, Ludomirsky A. Fetal cardiac rhabdomyoma: a sheep or a wolf? J Matern Fetal Neonatal Med 2007;20:343-348. (Pubitemid 47221609)
155. Foster ED, Spooner EW, Farina MA, Shaher RM, Alley RD. Cardiac rhabdomyoma in the neonate: surgical management. Ann Thorac Surg 1984;37:249-253. (Pubitemid 14160431)
156. Venugopalan P, Babu JS, Al-Bulushi A. Right atrial rhabdomyoma acting as the substrate for Wolff-Parkinson-White syndrome in a 3-month-old infant. Acta Cardiol 2005;60:543-545. (Pubitemid 41433662)
157. Case CL, Gillette PC, Crawford FA. Cardiac rhabdomyomas causing supraventricular and lethal ventricular arrhythmias in an infant. Am Heart J 1991;122:1484-1486.
158. Bini RM, Westaby S, Bargeron LM Jr, Pacifico AD, Kirklin JW. Investigation and management of primary cardiac tumors in infants and children. J Am Coll Cardiol 1983;2:351-357. (Pubitemid 13078803)
159. Holley DG, Martin GR, Brenner JI, et al. Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports.
160. Allen HD, Blieden LC, Stone FM, Bessinger FB Jr, Lucas RV Jr. Echocardiographic demonstration of a right ventricular tumor in a neonate. J Pediatr 1974;84:854-856.
161. Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV. Cardiac tumours in children. Orphanet J Rare Dis 2007;2:11.
162. Issacs H. Tumors of the Fetus and Infant: An Atlas. New York: Springer-Verlag, 2002.
163. Bussani R, Rustico MA, Silvestri F. Fetal cardiac rhabdomyomatosis as a prenatal marker for the detection of latent tuberous sclerosis: an autopsy case report. Pathol Res Pract 2001;197:559-561.
164. Wei J, Li P, Chiriboga L, et al. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Pediatr Dev Pathol 2002;5:448-464. (Pubitemid 35396805)
165. Smythe JF, Dyck JD, Smallhorn JF, Freedom RM. Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol 1990;66:1247-1249.
166. Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol 2000;21:317-323. (Pubitemid 30436520)
167. Wu SS, Collins MH, de Chadarevian JP. Study of the regression process in cardiac rhabdomyomas. Pediatr Dev Pathol 2002;5:29-36. (Pubitemid 34279696)
168. Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA. Surgical treatment for cardiac rhabdomyomas in children. Ann Thorac Surg 1994;58:1552-1555. (Pubitemid 24347568)
169. Shehata BM, Patterson K, Thomas JE, Scala-Barnett D, Dasu S, Robinson HB. Histiocytoid cardiomyopathy: three new cases and a review of the literature. Pediatr Dev Pathol 1998;1:56-69. (Pubitemid 128542112)
170. Walsh SN, Hurt MA. Cutaneous fetal rhabdomyoma: a case report and historical review of the literature. Am J Surg Pathol 2008;32:485-491. (Pubitemid 351398943)
171. Premalata CS, Kumar RV, Saleem KM, Fathima LJ, Das K. Fetal rhabdomyoma of the lower extremity. Pediatr Blood Cancer 2009;52:881-883.
172. Bozic C. Fetal rhabdomyoma of the parotid gland in an infant: histological, immunohistochemical, and ultrastructural features. Pediatr Pathol 1986;6:139-144. (Pubitemid 17013352)
173. Betlach J, Nozicka Z, Spacek J. Fetal rhabdomyoma of the mucosa of the lip. Cesk Patol 2000;36:21-25.
174. DiSanto S, Abt AB, Boal DK, Krummel TM. Fetal rhabdomyoma and nevoid basal cell carcinoma syndrome. Pediatr Pathol 1992;12:441-447.
175. Dahl I, Angervall L, Save-Soderbergh J. Foetal rhabdomyoma: case report of a patient with two tumours. Acta Pathol Microbiol Scand A 1976;84:107-112.
176. Hardisson D, Jimenez-Heffernan JA, Nistal M, Picazo ML, Tovar JA, Contreras F. Neural variant of fetal rhabdomyoma and naevoid basal cell carcinoma syndrome. Histopathology 1996;29:247-252. (Pubitemid 26302733)
177. di Sant'Agnese PA, Knowles DM. Extracardiac rhabdomyoma: a clinicopathologic study and review of the literature. Cancer 1980;46:780-789.
178. Kapadia SB, Meis JM, Frisman DM, Ellis GL, Heffner DK. Fetal rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study of 24 cases. Hum Pathol 1993;24:754-765. (Pubitemid 23204654)
179. Dehner LP, Enzinger FM, Font RL. Fetal rhabdomyoma: an analysis of nine cases. Cancer 1972;30:160-166.
180. Crotty PL, Nakhleh RE, Dehner LP. Juvenile rhabdomyoma: an intermediate form of skeletal muscle tumor in children. Arch Pathol Lab Med 1993;117:43-47. (Pubitemid 23027006)
181. Seidal T, Kindblom LG, Angervall L. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas: an immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies. Appl Pathol 1987;5:201-219. (Pubitemid 17144135)
182. Markel SF, Enzinger FM. Neuromuscular hamartoma: a benign "triton" tumor composed of mature neural and striated muscle elements. Cancer 1982;49:140-144. (Pubitemid 12196148)
183. De la Sotta P, Salomone C, Gonzalez S. Rhabdomyomatous (mesenchymal) hamartoma of the tongue: report of a case. J Oral Pathol Med 2007;36:58-59. (Pubitemid 44973990)
184. Han SH, Song HJ, Hong WK, Lee HS, Choi GS, Shin JH. Rhabdomyomatous mesenchymal hamartoma of the vagina. Pediatr Dermatol 2009;26:735-753.
185. Magro G, Di BA, Sanges G, Scalisi F, Alaggio R. Rhabdomyomatous mesenchymal hamartoma of oral cavity: an unusual location for such a rare lesion. Virchows Arch 2005;446:346-347. (Pubitemid 40558396)
186. Scrivener Y, Petiau P, Rodier-Bruant C, Cribier B, Heid E, Grosshans E. Perianal striated muscle hamartoma associated with hemangioma. Pediatr Dermatol 1998;15:274-276. (Pubitemid 28374466)
187. Steele JC, Triantafyllou A, Field EA. Lingual striated muscle hamartoma or herniation? J Oral Pathol Med 2004;33:454-455. (Pubitemid 39221347)
188. Sahn EE, Garen PD, Pai GS, Levkoff AH, Hagerty RC, Maize JC. Multiple rhabdomyomatous mesenchymal hamartomas of skin. Am J Dermatopathol 1990;12:485-491. (Pubitemid 20312681)
189. Sanchez RL, Raimer SS. Clinical and histologic features of striated muscle hamartoma: possible relationship to Delleman's syndrome. J Cutan Pathol 1994;21:40-46. (Pubitemid 24072854)
190. Read RW, Burnstine M, Rowland JM, Zamir E, Rao NA. Rhabdomyomatous mesenchymal hamartoma of the eyelid: report of a case and literature review. Ophthalmology 2001;108:798-804. (Pubitemid 32238480)
191. Adam MP, Abramowsky CR, Brady AN, Coleman K, Todd NW. Rhabdomyomatous hamartomata of the pharyngeal region with bilateral microtia and aural atresia: a new association? Birth Defects Res A Clin Mol Teratol 2007;79:242-248. (Pubitemid 46411284)
192. Biswas A, Gey van PD. Rhabdomyomatous mesenchymal hamartoma with lentiginous melanocytic hyperplasia: an inductive phenomenon or component of the hamartoma? Am J Dermatopathol 2008;30:488-491.
193. Coffin CM, Dehner LP, O'Shea PA. Pediatric Soft Tissue Tumors: A Clinical, Pathological, and Therapeutic Approach. Baltimore: Williams and Wilkins, 1997.
194. Yannopoulos K, Stout AP. Smooth muscle tumors in children. Cancer 1962;15:958-971.
195. Botting AJ, Soule EH, Brown AL Jr. Smooth muscle tumors in children. Cancer 1965;18:711-720.
196. Ceballos KM, Nielsen GP, Selig MK, O'Connell JX. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am J Clin Pathol 2000;114:746-753. (Pubitemid 33051911)
197. D'Addario SF, Morgan M, Talley L, Smoller BR. h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin. J Cutan Pathol 2002;29:426-429.
198. Hisaoka M, Wei-Qi S, Jian W, Morio T, Hashimoto H. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker. Appl Immunohistochem Mol Morphol 2001;9:302-308. (Pubitemid 33098138)
199. Watanabe K, Kusakabe T, Hoshi N, Saito A, Suzuki T. h- Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum Pathol 1999;30:392-396. (Pubitemid 29177817)
200. Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001;25:455-463. (Pubitemid 32240884)
201. Rush DS, Tan J, Baergen RN, Soslow RA. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001;25:253-258. (Pubitemid 32167508)
202. Balarezo FS, Joshi VV. Proliferative and neoplastic disorders in children with acquired immunodeficiency syndrome. Adv Anat Pathol 2002;9:360-370.
203. Swanson PE, Wick MR, Dehner LP. Leiomyosarcoma of somatic soft tissues in childhood: an immunohistochemical analysis of six cases with ultrastructural correlation. Hum Pathol 1991;22:569-577.
204. Gagne EJ, Su WP. Congenital smooth muscle hamartoma of the skin. Pediatr Dermatol 1993;10:142-145. (Pubitemid 23176141)
205. Gualandri L, Cambiaghi S, Ermacora E, Tadini G, Gianotti R, Caputo R. Multiple familial smooth muscle hamartomas. Pediatr Dermatol 2001;18:17-20. (Pubitemid 32163905)
206. Kreiger PA, Ernst LM, Elden LM, Kazahaya K, Alawi F, Russo PA. Hamartomatous tongue lesions in children. Am J Surg Pathol 2007;31:1186-1190. (Pubitemid 47207121)
207. Holland KE, Galbraith SS. Generalized congenital smooth muscle hamartoma presenting with hypertrichosis, excess skin folds, and follicular dimpling. Pediatr Dermatol 2008;25:236-239. (Pubitemid 351579612)
208. Zarineh A, Kozovska ME, Brown WG, Elder DE, Rabkin MS. Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature. J Cutan Pathol 2008;35(suppl 1):83-86.
209. Bourque MD, Spigland N, Bensoussan AL, et al. Esophageal leiomyoma in children: two case reports and review of the literature. J Pediatr Surg 1989;24:1103-1107. (Pubitemid 19253368)
210. Carney JA. The triad of gastric epithelioid leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma. Cancer 1979;43:374-382. (Pubitemid 9128842)
211. Blei E, Gonzalez-Crussi F. The intriguing nature of gastric tumors in Carney's triad: ultrastructural and immunohistochemical observations. Cancer 1992;69:292-300.
212. Carney JA. The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review. Medicine (Baltimore) 1983;62:159-169. (Pubitemid 13096629)
213. Perez-Atayde AR, Shamberger RC, Kozakewich HWP. Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad: an ultrastructural and immunohistochemical study. Am J Surg Pathol 1993;17:706-714. (Pubitemid 23180394)
214. Cochat P, Guyot C, Antignac C, et al. Pathological case of the month: Alport syndrome and diffuse leiomyomatosis. Am J Dis Child 1993;147:791-792.
215. Cochat P, Guibaud P, Garcia TR, Roussel B, Guarner V, Larbre F. Diffuse leiomyomatosis in Alport syndrome. J Pediatr 1988;113:339-343.
216. Kilpatrick SE, Mentzel T, Fletcher CD. Leiomyoma of deep soft tissue: clinicopathologic analysis of a series. Am J Surg Pathol 1994;18:576-582. (Pubitemid 24150806)
217. Lopez-Barea F, Rodriguez-Peralto JL, Burgos E, Gonzalez-Lopez J. Calcified leiomyoma of deep soft tissue: report of a case in childhood. Virchows Arch 1994;425:217-220. (Pubitemid 24312325)
218. De Mouy EH, Kaneko K, Rodriguez RP. Calcified soft tissue leiomyoma of the shoulder mimicking a chondrogenic tumor. Clin Imaging 1995;19:4-7.
219. Rogers BB, Grishaber JE, Mahoney DH, McGill CW, Wagner ML. Gastric leiomyoblastoma (epithelioid leiomyoma) occurring in a child: a case report. Pediatr Pathol 1989;9:79-85. (Pubitemid 19093592)
220. Thomas LA, Balaratnam N, Richards DG, Duane PD. Diffuse esophageal leiomyomatosis: another cause of pseudoachalasia. Dis Esophagus 2000;13:165-168.
221. Guillem P, Delcambre F, Cohen-Solal L, et al. Diffuse esophageal leiomyomatosis with perirectal involvement mimicking Hirschsprung disease. Gastroenterology 2001;120:216-220. (Pubitemid 32061886)
222. Federici S, Ceccarelli PL, Bernardi F, et al. Esophageal leiomyomatosis in children: report of a case and review of the literature. Eur J Pediatr Surg 1998;8:358-363. (Pubitemid 29035884)
223. Henke AC, Salomao DR, Timmerman TG, Hughes JH. Fine-needle aspiration cytology of esophageal leiomyomatosis. Diagn Cytopathol 1999;21:197-199. (Pubitemid 29398645)
224. Levine MS, Buck JL, Pantongrag-Brown L, Buetow PC, Lowry MA, Sobin LH. Esophageal leiomyomatosis. Radiology 1996;199:533-536. (Pubitemid 26122007)
225. Sell HW Jr, Cocco A. Diffuse leiomyomatosis of the gastrointestinal tract in a single patient: esophagus to rectum. Case report. Surgery 1997;122:637-640. (Pubitemid 27407088)
226. Thorner P, Heidet L, Moreno MF, Edwards V, Antignac C, Gubler MC. Diffuse leiomyomatosis of the esophagus: disorder of cell-matrix interaction? Pediatr Dev Pathol 1998;1:543-549. (Pubitemid 128542174)
227. Kugelman A, Greif Y, Gershoni-Baruch R, et al. Pulmonary presentation of esophageal leiomyomatosis associated with Alport syndrome in childhood. Isr Med Assoc J 2003;5:293-294. (Pubitemid 36637205)
228. Anker MC, Arnemann J, Neumann K, Ahrens P, Schmidt H, Konig R. Alport syndrome with diffuse leiomyomatosis. Am J Med Genet A 2003;119A:381-385. (Pubitemid 37063871)
229. Lonsdale RN, Roberts PF, Vaughan R, Thiru S. Familial oesophageal leiomyomatosis and nephropathy. Histopathology 1992;20:127-133.
230. Antignac C, Zhou J, Sanak M, et al. Alport syndrome and diffuse leiomyomatosis: deletions in the 59 end of the COL4A5 collagen gene. Kidney Int 1992;42:1178-1183.
231. Kumar P, Breach NM, Goldstraw P. Esophageal leiomyomatosis involving trachea: surgical resection and repair. Ann Thorac Surg 1997;63:531-533. (Pubitemid 27084587)
232. Ueki Y, Naito I, Oohashi T, et al. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet 1998;62:253-261. (Pubitemid 28110766)
233. Hachisuga T, Hashimoto H, Enjoji M. Angioleiomyoma: a clinicopathologic reappraisal of 562 cases. Cancer 1984;54:126-130. (Pubitemid 14117058)
234. Lack EE. Leiomyosarcomas in childhood: a clinical and pathologic study of 10 cases. Pediatr Pathol 1986;6:181-197. (Pubitemid 17013358)
235. Hwang ES, Gerald W, Wollner N, Meyers P, La Quaglia MP. Leiomyosarcoma in childhood and adolescence. Ann Surg Oncol 1997;4:223-227. (Pubitemid 127725248)
236. de Saint Aubain Somerhausen N, Fletcher CD. Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases. Am J Surg Pathol 1999;23:755-763. (Pubitemid 29307680)
237. Ferrari A, Bisogno G, Casanova M, et al. Childhood leiomyosarcoma: a report from the soft tissue sarcoma Italian Cooperative Group. Ann Oncol 2001;12:1163-1168. (Pubitemid 32834500)
238. Harms D. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. Curr Top Pathol 1995;89:31-45.
239. Parham DM, Webber BL, Jenkins JJ, Cantor AB, Maurer HM. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol 1995;8:705-710.
240. Dry SM, Jorgensen JL, Fletcher CD. Leiomyosarcomas of the oral cavity: an unusual topographic subset easily mistaken for nonmesenchymal tumours. Histopathology 2000;36:210-220. (Pubitemid 30145246)
241. Mendonca EF, Martins da SC, Meneghini AJ, Silva GB, Filho JA, Batista AC. Low-grade gingival leiomyosarcoma in a child. J Dent Child 2008;75:301-305.
242. Yanguas I, Goday J, Gonzalez-Guemes M, Lozano M, Soloeta R. Cutaneous leiomyosarcoma in a child. Pediatr Dermatol 1997;14:281-283. (Pubitemid 27332912)
243. Blaise G, Nikkels AF, Quatresooz P, Hermanns-Le T, Pierard GE. Childhood cutaneous leiomyosarcoma. Pediatr Dermatol 2009;26:477-479.
244. Kennedy AP Jr, Cameron B, Dorion RP, McGill C. Pediatric intestinal leiomyosarcomas: case report and review of the literature. J Pediatr Surg 1997;32:1234-1236. (Pubitemid 27475905)
245. Billings SD, Folpe AL, Weiss SW. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes. Am J Surg Pathol 2001;25:1134-1142. (Pubitemid 32777712)
246. Antonescu CR, Erlandson RA, Huvos AG. Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review. Am J Surg Pathol 1997;21:1281-1294. (Pubitemid 27460855)
247. Moran CA, Suster S, Abbondanzo SL, Koss MN. Primary leiomyosarcomas of the lung: a clinicopathologic and immunohistochemical study of 18 cases. Mod Pathol 1997;10:121-128. (Pubitemid 27110036)
248. Johnson MA, Gibbs DH, Gouldman J, Hanly M, Gadacz TR. Leiomyosarcoma of the colon: a second malignant neoplasm after treatment for a Wilms' tumor. Am J Surg 1999;65:6-10. (Pubitemid 29031538)
249. Bisogno G, Spiller M, Scarzello G, et al. Secondary leiomyosarcomas: a report of 4 cases. Pediatr Hematol Oncol 2005;22:181-187. (Pubitemid 40315518)
250. MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 2009;93:1159-1162.
251. Bisogno G, Sotti G, Nowicki Y, et al. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group. Cancer 2004;100:1758-1765. (Pubitemid 38456356)
252. Persson S, Kindblom L-G, Angervall L, Tisell L-E. Metastasizing gastric epithelioid leiomyosarcomas (leiomyoblastomas) in young individuals with long-term survival. Cancer 1992;70:721-732.
253. Rubin BP, Fletcher CD. Myxoid leiomyosarcoma of soft tissue, an underrecognized variant. Am J Surg Pathol 2000;24:927-936. (Pubitemid 30430480)
254. Weiss SW. Smooth muscle tumors of soft tissue. Adv Anat Pathol 2002;9:351-359.
255. Rao UN, Finkelstein SD, Jones MW. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol 1999;12:1001-1009.
256. Merchant W, Calonje E, Fletcher CDM. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 1995;27:525-532. (Pubitemid 26022751)
257. Dal Cin P, Sciot R, Fletcher CD, et al. Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes. J Pathol 1998;185:112-115.
258. Sreekantaiah C, Davis JR, Sandberg AA. Chromosomal abnormalities in leiomyosarcomas. Am J Pathol 1993;142:293-305. (Pubitemid 23026932)
259. Schneider BF, Lovell MA, Golden WL. Cytogenetic abnormalities in primary bronchopulmonary leiomyosarcoma of childhood. Cancer Genet Cytogenet 1998;105:145-151. (Pubitemid 28381629)
260. Kaste SC, Marina N, Fryrear R, et al. Peritoneal metastases in children with cancer. Cancer 1998;83:385-390. (Pubitemid 28317821)
261. Kumar S, Santi M, Vezina G, Rosser T, Chandra RS, Keating R. Epstein-Barr virus-associated smooth muscle tumor of the basal ganglia in an HIV+ child: case report and review of the literature. Pediatr Dev Pathol 2004;7:198-203. (Pubitemid 38715341)
262. Chadwick EG, Connor EJ, Hanson IC, et al. Tumors of smooth-muscle origin in HIV-infected children. JAMA 1990;263:3182-3184. (Pubitemid 20207664)
263. Jenson HB, Leach CT, McClain KL, et al. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma 1997;27:303-314. (Pubitemid 27501189)
264. Mueller BU, Butler KM, Higham MC, et al. Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1992;90:460-463.
265. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein- Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;332:12-18.
266. McLoughlin LC, Nord KS, Joshi VV, DiCarlo FJ, Kane MJ. Disseminated leiomyosarcoma in a child with acquired immune deficiency syndrome. Cancer 1991;67:2618-2621.
267. Lee ES, Locker J, Nalesnik M, et al. The association of Epstein- Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995;332:19-25.
268. Somers GR, Tesoriero AA, Hartland E, et al. Multiple leiomyosarcomas of both donor and recipient origin arising in a heart-lung transplant patient. Am J Surg Pathol 1998;22:1423-1428. (Pubitemid 28499134)
269. Deyrup AT, Lee VK, Hill CE, et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006;30:75-82. (Pubitemid 43740212)
270. Mierau GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol 1997;21:301-305. (Pubitemid 27237235)
271. Reyes C, Abuzaitoun O, De JA, Hanson C, Langston C. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review. Hum Pathol 2002;33:133-136. (Pubitemid 34112964)
272. Ha C, Haller JO, Rollins NK. Smooth muscle tumors in immunocompromised (HIV negative) children. Pediatr Radiol 1993;23:413-414. (Pubitemid 23342580)
273. Beral V, Newton R. Overview of the epidemiology of immunodeficiency- associated cancers. J Natl Cancer Inst Monogr 1998;23:1-6.
274. Barbashina V, Heller DS, Hameed M, et al. Splenic smooth-muscle tumors in children with acquired immunodeficiency syndrome: report of two cases of this unusual location with evidence of an association with Epstein-Barr virus. Virchows Arch 2000;436:138-139. (Pubitemid 30128761)
275. Monforte-Munoz H, Kapoor N, Saavedra JA. Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature. Pediatr Dev Pathol 2003;6:449-457. (Pubitemid 37323437)
276. Van Hoeven KH, Factor SM, Kress Y, Woodruff JM. Visceral myogenic tumors: a manifestation of HIV infection in children. Am J Surg Pathol 1993;17:1176-1181. (Pubitemid 23313792)
277. Molle ZL, Bornemann P, Desai N, Clarin E, Anderson V, Rabinowitz SS. Endoscopic features of intestinal smooth muscle tumor in a child with AIDS. Dig Dis Sci 1999;44:910-915. (Pubitemid 29205599)
278. Balsam D, Segal S. Two smooth muscle tumors in the airway of an HIV-infected child. Pediatr Radiol 1992;22:552-553. (Pubitemid 23023391)